C0184661||Intervention
C2364172||Medication Adherence
C1331016||Low-Income
C0011860||Type 2
C0746935||Nonadherence
C0011847||diabetes
C2081612||medication
C2718080||mobile health
C2718080||mobile health
C0184661||intervention
C1706077||user
C2364172||medication adherence
C1706077||users
C0679646||within-participant
C0019018||HbA1c
C0011860||type 2 diabetes
C0220825||assessment
C1706077||user
C1706077||users
C3178910||text messages
C0679646||participant
C0871472||t-tests
C0679646||within-participant
C3161035||regression models
C0679646||participant's
C0019018||HbA1c
C0679646||Participants
C0019018||HbA1c
C2081612||medications
C2081612||medications
C2081612||medications
C0679646||Participants
C3178910||text messages
C0679646||participants
C0019018||HbA1c
C1706077||users
C2718080||mobile health
C0184661||interventions
C1331016||low-income